Undervalued Stocks Based On Cash Flows

Resultados

31

8 nuevo

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

31 empresas

EmpresaÚltimo precio7D RetornoRendimiento 1 añoCapitalización bursátilObjetivo de los analistasValoraciónCrecimientoDiv RendimientoIndustria
1318
HK$55.953.6%-47.7%HK$27.4bHK$104.0919.717.2%2.1%Household
697
Nuevo
HK$1.613.9%-3.6%HK$13.1bHK$2.6642.337.3%2.3%Real Estate Management and Development
6181
Nuevo
HK$380.003.9%-63.3%HK$67.2bHK$891.6312.018.9%7.3%Consumer Durables
1180
HK$0.73-6.4%-15.1%HK$768.1mHK$1.3070.379.9%13.7%Consumer Services
2190
HK$19.736.5%-3.8%HK$6.6bHK$30.3123.425.4%1.3%Healthcare
2315
HK$50.006.7%135.3%HK$49.4bHK$62.0366.740.4%n/aPharmaceuticals & Biotech
2589
HK$94.65-22.2%-33.0%HK$10.0bHK$88.3517.214.3%2.4%Consumer Services
2338
HK$37.4811.2%144.6%HK$302.4bHK$45.5324.922.0%2.3%Capital Goods
6185
Nuevo
HK$24.007.0%-30.0%HK$10.2bHK$50.324.657.2%0%Pharmaceuticals & Biotech
6990
HK$523.5020.2%48.6%HK$122.1bHK$547.6451.444.8%n/aPharmaceuticals & Biotech
2698
HK$27.447.4%n/aHK$17.0bHK$40.5117.914.9%2.5%Household
1651
Nuevo
HK$70.6516.5%243.8%HK$26.0bHK$65.5920.615.1%2.5%Capital Goods
1801
HK$90.5013.1%9.6%HK$157.3bHK$117.32167.531.2%n/aPharmaceuticals & Biotech
9926
HK$101.9011.2%-9.8%HK$93.9bHK$171.7526.646.8%n/aPharmaceuticals & Biotech
9658
HK$9.823.6%-36.0%HK$6.4bHK$14.4528.530.5%n/aConsumer Services
1357
HK$4.118.7%-53.8%HK$18.7bHK$9.3222.131.4%2.4%Media
1060
HK$0.495.4%-45.6%HK$14.7bHK$0.9418.020.4%n/aMedia
2145
HK$27.08-4.0%-66.5%HK$10.8bHK$86.158.516.7%5.3%Household
3396
Nuevo
HK$12.90-4.4%44.9%HK$30.4bHK$13.5724.844.5%0.9%Tech
2252
HK$26.0010.5%65.4%HK$26.8bHK$37.3542.290.1%n/aHealthcare
2235
HK$7.383.7%23.0%HK$3.1bHK$11.8166.244.9%n/aHealthcare
1768
HK$396.0030.9%n/aHK$86.2bHK$512.1232.124.7%n/aConsumer Retailing
23
HK$12.66-0.8%2.8%HK$33.5bHK$14.260.325.9%4.8%Banks
3858
Nuevo
HK$56.301.9%n/aHK$25.7bHK$116.6084.154.8%n/aMaterials
Page 1 of 1